Chalita Atallah, MD
Epilepsy · Greenwood Village, CONPI 1265731418
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $5,815 of the $9,248 with a category attached, or 62.9%. 14 manufacturers reported payments, led by Sunovion Pharmaceuticals Inc. at 46.2% of the total. Reporting peaked in 2020 at $3,592 and has fallen 95.8% since, to $150 in 2025.
Across 53 payments — averaging $174.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$4K
- Livanova USA, Inc.$2K
- Ceribell, Inc.$873
- Medtronic$796
- ZOLL Medical Corporation$293
- UCB, Inc.$162
- plus $545 from 8 others
What the payments were for
- Consulting fees$2,34025%
- Speaking & faculty fees$5,81563%
- Travel & lodging$601%
- Food & beverage$1,03311%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 11 | $4,275 |
| Livanova USA, Inc. | 11 | $2,303 |
| Ceribell, Inc. | 4 | $873 |
| Medtronic | 3 | $796 |
| ZOLL Medical Corporation | 1 | $293 |
| UCB, Inc. | 11 | $162 |
| Jazz Pharmaceuticals Inc. | 1 | $146 |
| Eisai Inc. | 2 | $129 |
| Neurelis, Inc. | 1 | $105 |
| AbbVie | 4 | $97 |
| Sanofi | 1 | $21 |
| Lilly USA, LLC | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Greenwich Biosciences, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- APTIOM$4,138
- VNS Therapy$1,850
- Ceribell Rapid Response EEG$800
- VNS - Sentiva$400
- Epidiolex$146
- Fycompa$115
- VALTOCO$105
How this compares
$9,248 in reported general payments places this provider in the 85th percentile of 28 epilepsy providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other epilepsy in Greenwood Village
- Kelly KnuppAurora$39K
- Danielle McDermottDenver$31K
- Charles LivseyEnglewood$29K
- Scott DemarestAurora$15K
- Jacob PellinenAurora$6K
- Steve SavinoffParker$4K
- Jared WoodwardAurora$3K
- Samuel DestefanoLittleton$3K
- Megan AbbottAurora$2K
- Naveed ChaudhryAurora$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.